Trade CNS Pharmaceuticals, Inc. - CNSP CFD

Add to favourite

0.1087

7.84%

View detailed chart

To be able to trade stocks like this, create an account and apply for a stock listing.

Create Account

Summary
Historical Data

Trading сonditions

Spread

0.0016

Long position overnight fee

-0.024346%

Short position overnight fee

0.002124%

Overnight fee time

22:00 (UTC)

Min traded quantity

0.001

Currency

USD

Margin

5.00%

Stock exchange

United States of America

Commission on trade

Key Stats

Prev. Close	0.1008
Open	0.1036
1-Year Change	-93.96%
Day's Range	0.1036 - 0.1216

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Dec 17, 2024	0.1087	0.0041	3.92%	0.1046	0.1221	0.1026
Dec 16, 2024	0.1008	0.0008	0.80%	0.1000	0.1028	0.0996
Dec 13, 2024	0.0996	0.0000	0.00%	0.0996	0.1002	0.0966
Dec 12, 2024	0.1014	-0.0078	-7.14%	0.1092	0.1092	0.0995
Dec 11, 2024	0.1068	0.0011	1.04%	0.1057	0.1115	0.1035
Dec 10, 2024	0.1083	0.0036	3.44%	0.1047	0.1120	0.1012
Dec 9, 2024	0.1066	0.0070	7.03%	0.0996	0.1101	0.0960
Dec 6, 2024	0.1027	0.0021	2.09%	0.1006	0.1027	0.0952
Dec 5, 2024	0.1008	-0.0063	-5.88%	0.1071	0.1071	0.0996
Dec 4, 2024	0.1051	0.0030	2.94%	0.1021	0.1051	0.1007
Dec 3, 2024	0.1029	-0.0057	-5.25%	0.1086	0.1086	0.0986
Dec 2, 2024	0.1102	-0.0004	-0.36%	0.1106	0.1113	0.1046
Nov 29, 2024	0.1110	-0.0026	-2.29%	0.1136	0.1146	0.1096
Nov 27, 2024	0.1138	-0.0009	-0.78%	0.1147	0.1170	0.1116
Nov 26, 2024	0.1151	0.0045	4.07%	0.1106	0.1168	0.1106
Nov 25, 2024	0.1128	-0.0084	-6.93%	0.1212	0.1212	0.1102
Nov 22, 2024	0.1125	-0.0100	-8.16%	0.1225	0.1234	0.1096
Nov 21, 2024	0.1275	-0.0023	-1.77%	0.1298	0.1436	0.1256
Nov 20, 2024	0.1236	0.0013	1.06%	0.1223	0.1358	0.1197
Nov 19, 2024	0.1244	0.0098	8.55%	0.1146	0.1341	0.1116

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

1:1
2:1
3:1
5:1
10:1
20:1

Leverage

20:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

CNS Pharmaceuticals, Inc. Company profile

About CNS Pharmaceuticals Inc

CNS Pharmaceuticals Inc. is a clinical pharmaceutical company. The Company is focused on development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The Company is developing its lead drug candidate, Berubicin for the treatment of glioblastoma. Glioblastoma are tumors that arise from astrocytes, which are star-shaped cells making up the supportive tissue of the brain. Berubicin is an anthracycline, a class of drugs that are among the chemotherapy drugs, which intercalates into Deoxyribonucleic acid (DNA) and interrupts topoisomerase II activity, resulting in the inhibition of DNA replication and repair, and RNA and protein synthesis. The Company is advancing the development of its WP1244 drug technology, which utilizes anthracycline and distamycin-based scaffolds to create small molecule agents.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, CNS Pharmaceuticals Inc revenues was not reported. Net loss increased 48% to $14M. Higher net loss reflects Research and development increase of 85% to $9.3M (expense), Selling/General/Admin Expense increase of 7% to $4.7M (expense), Interest expense increase from $3K to $9K (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$0.57 to -$0.53.

Industry:

Biotechnology & Medical Research (NEC)

2100 West Loop S Ste 900
HOUSTON
TEXAS 77027-3522
US

News

Pi Network coin price prediction: Third party price target

Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com

13:51, 13 December 2024

Euro forecast: third party data roundup

In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.

22:39, 12 December 2024

Projected US interest rates in 5 years: Third party round up

As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?

14:28, 12 December 2024

Street in City of London with Royal Exchange, Bank of England and new modern skyscrapers

Projected UK interest rates in 5 years

Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?

11:20, 12 December 2024